Drug Shortage Report for TARO-VENLAFAXINE XR

Last updated on 2024-03-01 History
Report ID 178202
Drug Identification Number 02380099
Brand name TARO-VENLAFAXINE XR
Common or Proper name VENLAFAXINE
Company Name SUN PHARMA CANADA INC
Market Status MARKETED
Active Ingredient(s) VENLAFAXINE
Strength(s) 150MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size 100
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-12-08
Estimated end date 2024-03-23
Actual end date
Shortage status Actual shortage
Updated date 2024-03-01
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v30 2024-03-01 French Compare
v29 2024-03-01 English Compare
v28 2024-01-05 French Compare
v27 2024-01-05 English Compare
v26 2023-11-03 French Compare
v25 2023-11-03 English Compare
v24 2023-10-25 French Compare
v23 2023-10-25 English Compare
v22 2023-08-16 French Compare
v21 2023-08-16 English Compare
v20 2023-06-09 French Compare
v19 2023-06-09 English Compare
v18 2023-05-08 French Compare
v17 2023-05-08 English Compare
v16 2023-04-10 French Compare
v15 2023-04-10 English Compare
v14 2023-03-24 French Compare
v13 2023-03-24 English Compare
v12 2023-03-10 French Compare
v11 2023-03-10 English Compare

Showing 1 to 20 of 30